Fastbase Solutions goal is to develop its microscopy platform, QF-Pro®, into an easy-to-use marketable healthcare product, that contributes to enhance immune-oncology treatments of cancer patients. Fastbase was founded by leading scientists from Cancer Research UK. After promising trial results,they now require funding to launch QF-Pro® commercially.
n/a
n/a
n/a
n/a
n/a
Date | Amount | No. of Investors | |
---|---|---|---|
12/05/2022 | €231,135.75 | 412 | View |
Date | Description | Type |
---|
Name | Role | Appointed | Nationality |
---|